IFRS11 adjustments: for its operational reporting, the Group continues to integrate joint operations under the proportional integration method, considering that this presentation is a better ...
2024. The due date for payment of the Subsequent Offer Shares is 14 February. Subject to timely payment of the Subsequent Offer Shares subscribed for and allocated in the Subsequent Offering, and ...
In the fourth quarter, Group sales in Western Europe rose by 7.2% LFL (+7.4% on a reported basis). Over the full year, sales rose organically by 4.8% (+5.4% on a reported basis) in overall buoyant ...
Advicenne (Euronext Growth Paris ALDVI – FR0013296746) a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering from rare ...
Chassieu (France), 23 January 2025 – 6.00 pm - Amoéba (FR0011051598 - ALMIB), an industrial greentech specialising in the development of natural microbiological solutions based on the patented use of ...
Aalst, Belgium, January 23, 2025 – Ontex Group NV, a leading international developer and producer of personal care products, will share its results for the fourth quarter and full year 2024 at 07:00 ...
strategy and the market dynamics in the silicones business.
When: Thursday 6 February, 0900 CET / 0800 UKT. To subscribe to Press releases from this issuer, visit the Subscription to Company news section in your account section or create an account.
Luxembourg 23 January, 2025 (17:30 CET) - Aperam S.A. (Aperam), a global leader in stainless, specialty steel solutions and recycling, and Universal Stainless & Alloy Products, a premier supplier in ...
unaudited figures for Q4 2024 and full-year 2024: * Q4 2024 revenue of approximately NOK 396 million and full-year 2024 revenue of approximately NOK 1,876 million. This is equivalent to FY 2024 ...
price of NOK 4.50 per Subsequent Offer Share (the "Offer Price"), with gross proceeds of NOK 15,589,350 (the "Subsequent Offering"). prostate. The concept is scalable and can be extended to other ...
up to the Annual General Meeting 2025, resolve on a new issue of shares with or without preferential rights for the company's shareholders. If a share issue is carried out without preferential rights ...